<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T11:38:53Z</responseDate>
  <request identifier="oai:figshare.com:article/33919876" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33919876</identifier>
        <datestamp>2026-09-18T04:34:20Z</datestamp>
        <setSpec>category_696</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Disease-specific patterns of glymphatic-related dysfunction between multiple sclerosis and neuromyelitis optica spectrum disorder.pdf</dc:title>
          <dc:creator>Xiaoya Chen (487125)</dc:creator>
          <dc:creator>Kai Zhang (102844)</dc:creator>
          <dc:creator>Xiaojuan Dong (8682051)</dc:creator>
          <dc:creator>Xiaohui Zhang (81778)</dc:creator>
          <dc:creator>Zhuowei Shi (23808040)</dc:creator>
          <dc:creator>Zichun Yan (14796282)</dc:creator>
          <dc:creator>Qiyuan Zhu (14207267)</dc:creator>
          <dc:creator>Yuling Peng (13151592)</dc:creator>
          <dc:creator>Yongliang Han (6811136)</dc:creator>
          <dc:creator>Yongmei Li (227480)</dc:creator>
          <dc:subject>Genetic Immunology</dc:subject>
          <dc:subject>diffusion tensor image analysis along the perivascular space</dc:subject>
          <dc:subject>glymphatic system</dc:subject>
          <dc:subject>multiple sclerosis</dc:subject>
          <dc:subject>neuromyelitis optica spectrum disorder</dc:subject>
          <dc:subject>periventricular diffusivity</dc:subject>
          <dc:description>Background&lt;p&gt;Glymphatic dysfunction has been reported in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), yet disease-specific patterns of glymphatic-related impairment and their structural and cognitive consequences remain poorly characterized.&lt;/p&gt;Methods&lt;p&gt;This study enrolled 196 MS patients, 88 NMOSD patients, and 108 healthy controls (HC). Glymphatic-related function was assessed using diffusion tensor image analysis along the perivascular space (DTI-ALPS) and periventricular diffusivity (PVeD). Between-group differences, partial correlations with structural and clinical outcomes, AQP4 subgroup comparisons, mediation analyses, and subcortical atrophy-based subgroup analyses were performed to characterize disease-specific glymphatic-related impairment patterns.&lt;/p&gt;Results&lt;p&gt;MS showed more extensive glymphatic-related impairment than NMOSD, with significant reductions in both DTI-ALPS and PVeD compared to HC (all p&lt;0.001). PVeD was significantly reduced in NMOSD compared to HC in both cohorts (p ≤ 0.008), whereas DTI-ALPS differences in NMOSD relative to HC were inconsistent across cohorts, reaching significance only in the GE replication cohort. In MS, PVeD showed widespread structural and cognitive associations; in NMOSD, associations were restricted to ventricular and choroid plexus volumes. A parallel multiple mediation model showed that subcortical gray matter atrophy, but not lesion volume, independently mediated the association between PVeD and Symbol Digit Modalities Test performance in MS, a pattern absent in NMOSD. Stratified subgroup analysis showed a pattern consistent with a glymphatic-cognitive association specific to patients with greater subcortical atrophy in MS, although formal interaction tests did not reach statistical significance; no such association was observed in either atrophy subgroup in NMOSD. AQP4-seropositive, but not seronegative, NMOSD patients showed significantly lower glymphatic-related metrics than HC (p&lt;0.001); direct comparison between the two subgroups was not significant.&lt;/p&gt;Conclusion&lt;p&gt;Glymphatic-related dysfunction exhibits distinct disease-specific patterns in MS and NMOSD, with PVeD showing broader sensitivity across both cohorts. These findings support PVeD as a promising complementary glymphatic-related diffusion marker in inflammatory demyelinating disease, though causal and disease-mechanistic interpretations await validation in longitudinal and mechanistic studies.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T04:34:20Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fimmu.2026.1917373.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Disease-specific_patterns_of_glymphatic-related_dysfunction_between_multiple_sclerosis_and_neuromyelitis_optica_spectrum_disorder_pdf/33919876</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
